You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Spondyloarthritis - treatment
THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sieper J, van der Heijde D, Dougados M, et al
THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
Annals of the Rheumatic Diseases 2015;74:283.